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Tuesday, February 5, 2013 453astrips placed below. The membrane had 0.4 mm pores that allowed the cyto-
kines released from the CD4þT cells to reach the SM but prevented direct con-
tact between cells. We found a significant increase in Vmax when the SM were
in contact with the T cells (0.3250.02 l/s) compared to the co-culture without
contact (0.2550.01 l/s) or compared to the SM alone (0.2450.01 l/s; p=0.01).
Thus, contact between SM and CD4þT cells is necessary for modulation of SM
contractile properties and this may be mediated, at least in part, by increases in
(þ)insert myosin heavy chain and MLCK expression. Supported by: CIHR,
NIH-RO1HL103405.
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We have examined the structural consequences of methionine (Met) oxidation
in the calcium-sensing muscle regulatory protein calmodulin (CaM) using mo-
lecular dynamics simulations. Protein oxidation by reactive oxygen species
(ROS), and subsequent reduction by the antioxidant enzymemethionine sulfox-
ide reductase, has emerged as a crucial cell regulatory mechanism. In the con-
text of oxidative stress, protein oxidation is implicated in disease progression
and biological aging. Our goal is to bridge our understanding of muscle dys-
function and protein oxidation with atomic-level insights into site-specific me-
thionine oxidation and calmodulin structural dynamics. We have carried out
multiple 500 ns molecular dynamics simulations of explicitly solvated calmod-
ulin, both the calcium-bound (1cll) and apo (1cfc) crystal structures. Results
from preliminary simulations suggest that the structure of calcium bound
CaM is structurally insensitive to methionine oxidation, while methionine ox-
idation in apo CaM causes considerable changes the relative orientation of the
N-ter and C-ter lobes. Our work is a component of a larger study in which spec-
troscopic distance measurements and nuclear magnetic resonance experiments
are being carried out for site-specifically oxidized CaM in both the calcium
bound and apo biochemical states. We expect that our in silico results will bring
atomic-level insight to spectroscopic measurements, and will be integral to cre-
ating a more complete model for oxidation-induced changes in calmodulin
structural dynamics. Further, we anticipate that our results will be applicable
to the many biological and pharmaceutical contexts in which a detailed under-
standing of protein oxidation, function and structure relationships is sought.
This work is supported by an NIH grant to Dave Thomas (2R37AG026160-
06) and the Minnesota Supercomputing Institute.
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Myofilament Length Dependent Activation (LDA) forms the cellular basis of
the Frank-Starling law observed on the heart. LDA has been studied intensively
and appears to be modulated through various mechanisms, such as the compo-
sition of the contractile proteins and their phosphorylation status. However, the
cellular molecular mechanisms that underlie this phenomenon are still not well
characterized.
The aim of our study is to determine whether LDA is regulated through cTnC
structural changes upon stretch. Accordingly, we used a single attached skinned
cardiac myocyte in combination with confocal fluorescent measurement. using
this technique, we found that stretch of a relaxed cell, in the absence of Ca2þ,
resulted in marked alterations of cTnC structure as reported by cTnC-T53C-
IAF confocal fluorescence. Moreover, titin mutant cells show a drastic alter-
ation of both passive tension and myofilament sensitivity to calcium (pCa50)
upon stretch. Consistent with this finding, by employing time-resolved x-ray
diffraction of intact, electrically stimulated rat myocardium, we found marked
changes in troponin and myosin structure upon stretch in the diastolic phase
(i.e. when cross-bridges are not active). Moreover, we repeated these x-ray ex-
periments using rat myocardium that expresses an unusually long titin molecule
and found that, when compared toWT, diastolic stretch in these muscles did not
cause structural changes in troponin and myosin structures. These results
strongly implicate titin to be the molecule that transmits the length signal for
LDA.
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Striated muscles are relaxed under low calcium concentration conditions due to
actions of the thin filament protein troponin. To investigate this regulatory
mechanism, this project studies the dynamic behavior of a mutant troponin
in which an 11-residue segment of cardiac troponin I, known as the inhibitoryregion, has been converted to a Gly-Ala flexible linker. The functional effects
of this mutation were previously characterized. (Mouannes Kozaili, et al, JBC
2010). The mutation impairs rather than abolishes troponin’s inhibitory func-
tion, and thin filaments retain cooperative Ca2þ-sensitive properties. Previous
work from our lab has mapped the dynamic behavior of the Ca2þ-saturated car-
diac troponin core domain at 10C and 25C using hydrogen/deuterium ex-
change (HDX)-mass spectrometry. (Kowlessur D, et al, JBC 2010, JBC
2010a). Also, another previous study established the effects of Ca2þ binding
to site II of TnC in the NH2 domain on troponin dynamics, using the TnC mu-
tant D65A/E66A (CBMII-TnC) (Manuscript Submitted).
To better understand troponin function, the dynamic behavior of site II Ca2þ-
free troponin (i.e. troponin with CBMII-TnC) containing the TnI inhibitory
peptide mutation is investigated in this work. HDX can determine the effect
of a specific alteration in a protein on the dynamics of all parts of that protein.
The results show that mutation of the inhibitory region alters troponin dynamics
both locally and at distance. The inhibitory region replacement slowed the dy-
namics of some regions, had no effect on others, and increased the dynamic
properties of much of the troponin coiled-coil. Some of the effects of Ca2þ re-
moval on troponin dynamics were dependent upon presence of the intact inhib-
itory region. The current work indicates a clear and complex effect of the
inhibitory peptide region on many portions of troponin.
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Muscle contraction is activated through Ca2þ-binding to TnC, leading to tropo-
myosin movement and unblocking of myosin binding sites on actin. To eluci-
date this regulatory mechanism, the 3D organization of the regulatory proteins
on the thin filament must be determined. While tropomyosin arrangement has
been determined by 3DEM using helical reconstruction and IHRSR analysis,
troponin was not visualized due to helical averaging. To solve the structure
of native cardiac thin filaments in low-Ca2þ, we have used single particle re-
construction of negatively stained specimens, without imposing actin helical
symmetry. To acquire identical particles for reconstruction, a cross-
correlation approach was applied to determine the axial position of troponin.
The reconstruction had a resolution of 2.5 nm. Nine different reference models
were used to test for any model bias in the reconstruction. Eight were variations
of an earlier model (Pirani et al., JMB, 2006), with troponin translated52 nm
along or 520oazimuthally around the filament, or tilted 515oradially or azi-
muthally; one model used a sphere to represent troponin. With eight of the
models, the reconstruction converged to the same final structure, which clearly
showed F-actin, tropomyosin and troponin densities. Consistency between re-
constructions from multiple different models indicates that the troponin densi-
ties are reliable. Atomic models of tropomyosin and actin fitted well into the
reconstruction. The densities attributable to troponin were also well fitted by
the cardiac troponin core domain (Takeda et al., Nature 2003), with the Tn
‘‘IT’’ arm projecting at ~50o to the filament axis (cf. Knowles et al., JMB
2012). The core domain orientation and the TnT tail, observed as a widening
of tropomyosin toward the barbed end of filaments, established the polarity
of troponin on the thin filament. Our 3DEM also is consistent with cross-
linking data localizing troponin on actin-tropomyosin.
TRP Channels
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The transient receptor potential ankyrin 1 channel (TRPA1) is a versatile sen-
sory channel that is gated by depolarizing voltages, deep cooling, membrane
deformation, and structurally diverse compounds which include proalgesic
agents such as allyl isothiocyanate. How these disparate stimuli converge on
the channel protein to open the ion-conducting pore has not yet been fully re-
solved. The overall architecture of TRP channels shows clear similarities to that
seen in the well characterized voltage-gated potassium channels. Here,
454a Tuesday, February 5, 2013activation of the voltage sensors in the fourth transmembrane segment (S4) is
transduced into pore opening via coupling of the S4-S5 linker to the C-terminal
S6 segment. In TRPA1, the gain-of-function mutation N855S located in the S4-
S5 region has been associated with familial episodic pain syndrome. In an at-
tempt to elucidate the role of the S4-S5 linker and its putative interaction(s)
with S6 or the first C-terminal helix in the voltage-dependent gating of
TRPA1, we used site-directed mutagenesis, whole-cell electrophysiology,
single-channel recording, and molecular dynamics simulations. The charge-
reversal mutations K868E and K969E resulted in a decrease in the rectification
index compared to wild-type TRPA1 channels, and a virtually voltage-
independent conductance-voltage (G-V) relationship. This effect was also ob-
served in the adjacent charge-neutralizing mutant H970A, but was less pro-
nounced in charge- reversal H970D. These results indicate that positively
charged residues in the S4-S5 linker and the helix adjacent to the C-terminal
S6 segment play a vital role in the voltage-dependent gating of TRPA1.
This work was supported by Czech Science Foundation Grant 305/09/0081, Re-
search Project Fund of the Academy of Sciences of the Czech Republic Grant
RVO:67985823, and Ministry of Education, Youth and Sports of the Czech Re-
public Grants OP VK CZ.1.07/2.3.00/30.0025, MSM0021620835, SVV-2010-
261 304, and GAUK 426311.
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Human skin is constantly exposed to solar ultraviolet radiation (UVR), the most
prevalent environmental carcinogen. Humans have the unique ability among
mammals to respond to UVR by increasing their skin pigmentation, a protective
process driven by melanin synthesis in epidermal melanocytes. However, the
mechanism used by melanocytes to detect and respond to UVR is not well un-
derstood. Here we report that transient receptor potential A1 (TRPA1) ion
channels expressed in human melanocytes are activated by UVR and mediate
early melanin synthesis. We show that in human epidermal melanocytes
(HEMs) physiological doses of UVR activate a retinal-dependent current me-
diated by TRPA1. The UVR photocurrent density was reduced by TRPA1 an-
tagonists and abolished in HEMs expressing TRPA1-targeted miRNA. The
TRPA1 photocurrent is UVA specific and requires G protein signaling, provid-
ing the first evidence for TRPA1 function in mammalian phototransduction. In
HEMs, TRPA1 activation contributes to UVR-induced calcium responses to
mediate downstream cellular effects. Remarkably, the UVR-induced and
retinal-dependent early increase in cellular melanin content was significantly
reduced in HEMs treated with TRPA1 antagonists and abolished in HEMs ex-
pressing TRPA1-targeted miRNA, suggesting that TRPA1 is required for early
melanin synthesis. Our results show that TRPA1 is essential for a novel extra-
ocular phototransduction pathway in human melanocytes that is activated by
physiological doses of UVR and results in early melanin synthesis.
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Canonical transient receptor potential channels (TRPC3/6) are mechano-
sensitive, receptor- and store-operated channels that mediate Ca2þ/Naþ influx
into cells. TRPC3/6 are implicated in the regulation of vascular tone, cell
growth, proliferation and pathological hypertrophy. Potent and selective small
molecule TRPC3/6 agonist and antagonist tools had been lacking to study the
functions of TRPC3/6. We report here potent, small molecule agonist
(GSK1702934A) and antagonists (GSK417651A and GSK2293017A) of
TRPC3/6. Whole-cell patch-clamp experiments demonstrated that
GSK1702934A activated TRPC3 and TRPC6 current in HEK293 cells trans-
duced with recombinant human TRPC3 or TRPC6 with an EC50 of ~
0.08 mM and 0.44 mM, respectively. GSK417651A inhibited both TRPC3
and TRPC6 current with IC50s of ~ 0.04 mM. A more potent TRPC3/6 antago-
nist GSK2293017A exhibited an IC50 of ~ 0.01 mM. GSK417651A was likely
acting on TRPC3/6 from the extracellular side, because dialyzing the cells with
10 mM GSK417651A in the pipette solution did not prevent the activation of
TRPC6. In the rat cardiomyocyte like cell line H9C2, GSK1702934A
(1 mM) activated TRPC6-like current which was completely blocked by
GSK417651A (1 mM). TRPC3/6 activator GSK1702934A (1 mM) transientlyincreased the perfusion pressure of isolated rat heart retrogradely perfused
via aortic cannulation. This effect was completely eliminated by pretreatment
with the TRPC3/6 blocker GSK2293017A (1 mM). IV bolus of GSK1702934A
(0.3 ~ 3 mg/kg) transiently increased blood pressure by 15 ~ 35 mmHg in con-
scious Sprague Dawley rats. This blood pressure effect was dose-dependently
inhibited by pretreatment of GSK2293017A (2.5 ~ 250 mg/kg/min infusion for
30 min) with complete inhibition occurring at a free plasma concentration of
0.81 mM. Therefore, these small molecule agonist and antagonists could be use-
ful tools to help understand the characteristics and functions of TRPC3/6 in tis-
sues and animals.
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Subfamily of human expressed TRPC channels (TRPC3/6/7) are activated by
‘diacylglycerol’ (DAG), a phospholipase C (PLC) hydrolyzed product of phos-
phatidylinositol 4,5-bisphosphate [PI(4,5)P2] (Hofmann et al., 1999, Nature).
In contrary, we have recently reported that the depletion of PI(4,5)P2 by-
itself act as a potent negative regulator to all these channels even in the pres-
ence of DAG (Imai et al., 2012, J. of Physiol.). Stimulation upon the vasocon-
strictile receptors coupled with PLC theoretically causes inseparable bimodal
effect to these TRPC channels, i.e. activation and inhibition by DAG produc-
tion and coincident PI(4,5)P2 reduction or depletion which is corresponding
to the strength of PLC activities. Here, to elucidate such self-limiting regulatory
function coupled to PI(4,5)P2-DAG signal, we simultaneously measure
TRPC6/7 currents in the whole-cell configuration and PI(4,5)P2 dynamics by
FRET using PI(4,5)P2 binding PH-domain sensor proteins in the various
strength of muscarinic- or vasopressin-receptor stimulation. Our simultaneous
detection approach reveals good kinetics correlation between TRPC activation/
fast-inactivation and PI(4,5)P2 depletion. Furthermore, a simple self-limiting
regulation model wherein experimentally determined PI(4,5)P2 binding con-
stants incorporated aware an emergence of fast recovery of PI(4,5)P2 to pro-
duce slow inactivation (plateau phase) of TRPC currents. We find that such
model implicated PI(4,5)P2 enhancement can be reproduced after the fast
PI(4,5)P2 depletion under the robust agonist stimulation by the local FRET
measurement near the channels. Hence, these data indicates that self-limiting
regulation coupled to PI(4,5)P2-DAG signal is the pivotal mechanism to under-
stand the receptor-PLC mediated TRPC3/6/7 channels activity.
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Canonical transient receptor potential (TRPC) channels have six transmem-
brane (6-TM) domains and are Ca2þ-permeable and non-selective cation chan-
nels. It is generally speculated that TRPC channels are activated by stimulation
of Gq-PLC-coupled receptors and oxidation. Activator of G-protein signaling1
(AGS1 or RASD1), the ras-related protein, interacts with Gi/Go and activates
heterotrimeric G-protein signaling systems independent of G-protein-coupled
receptor (GPCR). It is previously reported that AGS1 is related to GIRK chan-
nel and Ca2þ channel. However it is unknown whether AGS1 is associated with
TRPC channels. We assumed that AGS1 might regulate TRPC4 channel, since
AGS1 interacts with Gi/Go and TRPC4 is activated by Gi/o subunits. Here, we
measured whole cell current of TRPC4/5 after the co-expression of TRPC4 or
TRPC5 with constitutively active form of small GTPases in HEK293 cells.
AGS1 (CA) mutant (Q to L) activated TRPC4 (38.8 5 7.2 pA/pF) without
GTPgS and independently of GPCR. Pertussis toxin (PTX), Gai specific inhib-
itor, blocked RASD1-activated TRPC4 current (3.451.6 pA/pF). When co-
expressed with dominant negative Gai protein subtype, TRPC4 activation by
RASD1 was completely inhibited. With previous report that TRPC4 are acti-
vated primarily by selective Gai subunits rather than Gaq, these results suggest
that AGS1 activates TRPC4 channel through modulating Gai subunits and
AGS1 is a new activator for TRPC4 channel.
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The Transient Receptor Potential Canonical 4 (TRPC4) channel is a Ca2þ-per-
meable, non-selective cation channel in mammalian cells and mediates
